A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme☆

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC8056978 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature